SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-23-000138
Filing Date
2023-10-30
Accepted
2023-10-30 06:02:45
Documents
3
Period of Report
2023-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k_103023.htm 6-K 1113382
2 EX-99.1 financialappendix.htm EX-99.1 742217
3 GRAPHIC image.jpg GRAPHIC 8056
  Complete submission text file 0001395064-23-000138.txt   1867789
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 231357076
SIC: 2834 Pharmaceutical Preparations